Upgrade to SI Premium - Free Trial

Regeneron Pharma (REGN) PT Raised to $684 at Cowen

August 6, 2020 8:13 AM
Cowen analyst Yaron Werber raised the price target on Regeneron Pharma (NASDAQ: REGN) to $684.00 (from $584.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles